Published in J Immunol on April 15, 1987
Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem J (1989) 2.54
Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. Am J Pathol (1997) 1.49
Progress in molecular and genetic studies of IgA nephropathy. J Clin Immunol (2001) 1.34
The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells. Am J Pathol (1996) 1.29
Acylation of monocyte and glomerular mesangial cell proteins. Myristyl acylation of the interleukin 1 precursors. J Clin Invest (1988) 1.25
Cell cycle-dependent interleukin 1 gene expression by cultured glomerular mesangial cells. J Clin Invest (1988) 1.20
Mechanisms of immune-deposit formation and the mediation of immune renal injury. Clin Exp Nephrol (2005) 1.19
DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes. J Clin Invest (2003) 1.18
The N-terminal propiece of interleukin 1 alpha is a transforming nuclear oncoprotein. Proc Natl Acad Sci U S A (1997) 1.18
Stimulation of human rheumatoid synovial cells by non-lethal complement membrane attack. Immunology (1990) 1.12
Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis. Am J Pathol (1992) 1.07
Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain. Am J Pathol (1993) 1.06
Modulation of collagen synthesis in human glomerular epithelial cells by interleukin 1. Clin Exp Immunol (1989) 1.03
CD59a deficiency exacerbates ischemia-reperfusion injury in mice. Am J Pathol (2004) 0.98
The complement-inhibiting protein, protectin (CD59 antigen), is present and functionally active on glomerular epithelial cells. Clin Exp Immunol (1991) 0.98
Complement activation in human lymphoid germinal centres. Immunology (1989) 0.95
Activation of glomerular mesangial cells by gram-negative bacterial cell wall components. Am J Pathol (1988) 0.92
Complement and dilated cardiomyopathy: a role of sublytic terminal complement complex-induced tumor necrosis factor-alpha synthesis in cardiac myocytes. Am J Pathol (2002) 0.88
Modulation of leukocyte recruitment and IL-8 expression by the membrane attack complex of complement (C5b-9) in a rabbit model of antigen-induced arthritis. Inflammation (2002) 0.88
Leaked protein and interstitial damage in the kidney: is complement the missing link? Clin Exp Immunol (2002) 0.83
Role of complement and complement regulatory proteins in the complications of diabetes. Endocr Rev (2015) 0.82
Antibodies against mesangial cells and their secretory products in chronic renal allograft rejection in the rat. Am J Pathol (1998) 0.82
Interaction of the terminal complement components C5b-9 with synovial fibroblasts: binding to the membrane surface leads to increased levels in collagenase-specific mRNA. Immunology (1993) 0.82
Immunolocalization and characterization of the rat analogue of human CD59 in kidney and glomerular cells. Immunology (1993) 0.81
Detection of the terminal fluid-phase complement complex, SC5b-9, in the plasma of patients with insulin-dependent (type I) diabetes mellitus. Relation to increased urinary albumin excretion and plasma von Willebrand factor. Clin Exp Immunol (1991) 0.78
Acute serum sickness in normal and C6 deficient rabbits: role of membrane attack complex. Int J Exp Pathol (1992) 0.77
The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J (1999) 5.47
An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A (1996) 3.79
Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J Immunol (1982) 3.24
Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha. Biochem J (1989) 2.85
Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol (1988) 2.58
Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol Cell Biol (1999) 2.39
Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol (1997) 2.00
Programmed cell death (apoptosis) in human monocytes infected by influenza A virus. Immunobiology (1994) 1.98
Stimulation of rat mesangial cell proliferation by macrophage interleukin 1. J Immunol (1983) 1.94
Neutral proteinase activity produced in vitro by cells of the glomerular mesangium. Kidney Int (1983) 1.81
The interaction of the EcoRI restriction endonuclease with its substrate. A physico-chemical study employing natural and synthetic oligonucleotides and polynucleotides. Eur J Biochem (1980) 1.75
The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J Biol Chem (1997) 1.62
A thymocyte-activating factor derived from glomerular mesangial cells. J Immunol (1983) 1.59
Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells. Kidney Int (1990) 1.57
Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J Biol Chem (1994) 1.55
Isolation and characterization of lymphocyte plasma membranes. Biochim Biophys Acta (1972) 1.54
Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha. J Immunol (1988) 1.53
Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running. Clin Immunol Immunopathol (1992) 1.51
Kinetics of the transformation of Gram-negative rods to spheroplasts and ghosts by serum. J Immunol (1966) 1.51
Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response. J Leukoc Biol (1997) 1.51
The NF-kappa b repressing factor is involved in basal repression and interleukin (IL)-1-induced activation of IL-8 transcription by binding to a conserved NF-kappa b-flanking sequence element. J Biol Chem (2000) 1.44
Impairment of macrophage eicosanoid and nitric oxide production by an alkaloid from Sinomenium acutum. Arzneimittelforschung (1994) 1.43
Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1. J Biol Chem (1997) 1.39
Influenza A virus infection of macrophages. Enhanced tumor necrosis factor-alpha (TNF-alpha) gene expression and lipopolysaccharide-triggered TNF-alpha release. J Immunol (1991) 1.39
Influence of blood volume on cerebrospinal fluid levels of arachidonic acid metabolites after subarachnoid hemorrhage: experimental study on the pathogenesis of cerebral vasospasm. Neurosurgery (1988) 1.39
Role of macrophage cytokines in influenza A virus infections. Immunobiology (1993) 1.39
Functional expression of NADPH oxidase components (alpha- and beta-subunits of cytochrome b558 and 45-kDa flavoprotein) by intrinsic human glomerular mesangial cells. J Biol Chem (1991) 1.38
Cell culture approaches to the analysis of glomerular inflammation. Kidney Int (1986) 1.37
Tumor necrosis factor-alpha production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides. J Immunol (1990) 1.36
Interleukin 1 and the glomerular mesangium. I. Purification and characterization of a mesangial cell-derived autogrowth factor. J Immunol (1986) 1.34
The 31-kDa precursor of interleukin 1 alpha is myristoylated on specific lysines within the 16-kDa N-terminal propiece. Proc Natl Acad Sci U S A (1993) 1.33
TPA-induced differentiation and adhesion of U937 cells: changes in ultrastructure, cytoskeletal organization and expression of cell surface antigens. Eur J Cell Biol (1989) 1.32
Chemokines in the cerebrospinal fluid of patients with meningitis. Clin Immunol Immunopathol (1996) 1.31
Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages. J Leukoc Biol (2001) 1.30
Interleukin 1: more than a mediator between leukocytes. Trends Pharmacol Sci (1988) 1.30
Antibody-mediated target cell lysis by non-immune cells. Characterization of the antibody and effector cell populations. Eur J Immunol (1972) 1.27
Myristyl acylation of the tumor necrosis factor alpha precursor on specific lysine residues. J Exp Med (1992) 1.26
Acylation of monocyte and glomerular mesangial cell proteins. Myristyl acylation of the interleukin 1 precursors. J Clin Invest (1988) 1.25
Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation. J Biol Chem (1996) 1.25
Inhibition of Eco RI action by polynucleotides. A characterization of the non-specific binding of the enzyme to DNA. Nucleic Acids Res (1980) 1.25
A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription. J Biol Chem (1998) 1.25
Coxsackievirus B3-induced production of tumor necrosis factor-alpha, IL-1 beta, and IL-6 in human monocytes. J Immunol (1992) 1.25
Macrophages release arachidonic acid, prostaglandin E2, and thromboxane in response to late complement components. J Immunol (1984) 1.24
Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest (1995) 1.21
Prostaglandin synthesis in spleen cell cultures of mice injected with Corynebacterium parvum. Cell Immunol (1978) 1.20
Characterization of blood mononuclear cells of rheumatoid arthritis patients. I. Depressed lymphocyte proliferation and enhanced prostanoid release from monocytes. Clin Immunol Immunopathol (1982) 1.18
The N-terminal propiece of interleukin 1 alpha is a transforming nuclear oncoprotein. Proc Natl Acad Sci U S A (1997) 1.18
Glucocorticoids inhibit prostaglandin synthesis not only at the level of phospholipase A2 but also at the level of cyclo-oxygenase/PGE isomerase. Br J Pharmacol (1989) 1.17
The effects of phagocytosis, dextran sulfate, and cell damage on PGE1 sensitivity and PGE1 production of macrophages. J Immunol (1978) 1.17
Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection. J Exp Med (1996) 1.17
Mesangial cell hillocks. Nodular foci of exaggerated growth of cells and matrix in prolonged culture. Am J Pathol (1986) 1.16
Infection of macrophages by influenza A virus: characteristics of tumour necrosis factor-alpha (TNF alpha) gene expression. Res Virol (1997) 1.15
Thrombospondin secretion by cultured human glomerular mesangial cells. Am J Pathol (1987) 1.14
Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2. J Immunol (1989) 1.13
Macrophage cytotoxicity: interleukin 1 as a mediator of tumor cytostasis. J Immunol (1986) 1.13
Prostaglandin E2 production is synergistically increased in cultured human glomerular mesangial cells by combinations of IL-1 and tumor necrosis factor-alpha 1. J Immunol (1989) 1.11
Differential mononuclear leukocyte attracting chemokine production after stimulation with active and inactivated influenza A virus. Cell Immunol (1998) 1.11
Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase. Am J Pathol (1994) 1.11
Interleukin 1: the patterns of translation and intracellular distribution support alternative secretory mechanisms. J Cell Physiol (1992) 1.10
The MAPK kinase kinase TAK1 plays a central role in coupling the interleukin-1 receptor to both transcriptional and RNA-targeted mechanisms of gene regulation. J Biol Chem (2000) 1.10
MIF expression in the rat brain: implications for neuronal function. Mol Med (1998) 1.10
Zinc can increase the activity of protein kinase C and contributes to its binding to plasma membranes in T lymphocytes. J Biol Chem (1988) 1.10
The purification and characterization of a glomerular-basement-membrane-degrading neutral proteinase from rat mesangial cells. Biochem J (1988) 1.09
Glomerular mesangial cells in local inflammation. Induction of the expression of MHC class II antigens by IFN-gamma. J Immunol (1989) 1.09
Stress-activated protein kinase/Jun N-terminal kinase is required for interleukin (IL)-1-induced IL-6 and IL-8 gene expression in the human epidermal carcinoma cell line KB. J Biol Chem (1998) 1.08
Proteinases and glomerular matrix turnover. Kidney Int (1992) 1.08
Defense against influenza A virus infection: essential role of the chemokine system. Immunobiology (2001) 1.07
Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: modulation and/or suppression by inflammatory cytokines. Clin Exp Immunol (1991) 1.07
Induction of cytokines and chemokines in human monocytes by Mycoplasma fermentans-derived lipoprotein MALP-2. Infect Immun (1999) 1.07
Macrophage-activating factors from different T cell clones induce distinct macrophage functions. J Immunol (1983) 1.06
Release of cyclic AMP from macrophages by stimulation with prostaglandins. J Immunol (1975) 1.06
Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest (1996) 1.06
Intrinsic human glomerular mesangial cells can express receptors for IgG complexes (hFc gamma RIII-A) and the associated Fc epsilon RI gamma-chain. J Immunol (1994) 1.05
Human fibroblasts release low amounts of reactive oxygen species in response to the potent phagocyte stimulants, serum-treated zymosan, N-formyl-methionyl-leucyl-phenylalanine, leukotriene B4 or 12-O-tetradecanoylphorbol 13-acetate. Biol Chem Hoppe Seyler (1990) 1.05
Modulation of enzyme activities in isolated lymphocyte plasma membranes by enzymatic modification of phospholipid fatty acids. J Biol Chem (1981) 1.05
The effect of several nucleic acid binding drugs on the cleavage of d(GGAATTCC) and pBR 322 by the Eco RI restriction endonuclease. Nucleic Acids Res (1981) 1.05
Human mesangial cells secrete a GBM-degrading neutral proteinase and a specific inhibitor. Kidney Int (1989) 1.05
The mesangium and glomerulonephritis. Klin Wochenschr (1982) 1.04
Enhancement of glomerular mesangial cell neutral proteinase secretion by macrophages: role of interleukin 1. J Immunol (1986) 1.04
Phospholipid metabolism of stimulated lymphocytes. Composition of phospholipid fatty acids. Biochim Biophys Acta (1975) 1.03
Control of prostanoid synthesis: role of reincorporation of released precursor fatty acids. Prostaglandins (1986) 1.03
T-cell antigen receptor-induced signal-transduction pathways--activation and function of protein kinases C in T lymphocytes. Eur J Biochem (1995) 1.03
Different protein kinase C isoenzymes regulate IL-2 receptor expression or IL-2 synthesis in human lymphocytes stimulated via the TCR. J Immunol (1998) 1.02
Induction of lymphocyte proliferation and membrane changes by lipopeptide derivatives of the lipoprotein from the outer membrane of Escherichia coli. Z Immunitatsforsch Immunobiol (1977) 1.01
Drugs which disrupt microtubules do not inhibit the initiation of lymphocyte activation. Nature (1977) 1.01
Lysozyme and serum bactericidal action. Nature (1966) 1.01
Interleukin-1-induced activation of a protein kinase co-precipitating with the type I interleukin-1 receptor in T cells. Eur J Immunol (1994) 1.00
Monokines and platelet-derived growth factor modulate prostanoid production in growth arrested, human mesangial cells. Kidney Int (1990) 1.00
Phospholipid metabolism of stimulated lymphocytes: activation of acyl-CoA:lysolecithin acyltransferases in microsomal membranes. Biochim Biophys Acta (1973) 0.99
The inflammatory function of renal glomerular mesangial cells and their interaction with the cellular immune system. Clin Investig (1992) 0.99
Regulation of mesangial cell proliferation. Am J Kidney Dis (1991) 0.97
Tissue-specific enhancer-promoter interactions regulate high level constitutive expression of matrix metalloproteinase 2 by glomerular mesangial cells. J Biol Chem (1995) 0.97
Molecular characterization of a low-molecular-mass matrix metalloproteinase secreted by glomerular mesangial cells as PUMP-1. Biochem J (1992) 0.97